227 related items for PubMed ID: 17573408
1. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
Abeyagunawardena AS, Trompeter RS.
Arch Dis Child; 2008 Mar; 93(3):226-8. PubMed ID: 17573408
[Abstract] [Full Text] [Related]
2. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
[Abstract] [Full Text] [Related]
3. Towards evidence based medicine for paediatricians. Does daily prednisolone reduce the risk of relapse secondary to viral infections in steroid-dependent nephrotic syndrome?
Hasan F.
Arch Dis Child; 2009 Feb; 94(2):168-9. PubMed ID: 19158142
[No Abstract] [Full Text] [Related]
4. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
Christian MT, Webb NJ, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
[Abstract] [Full Text] [Related]
5. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ, PREDNOS 2 study group.
Trials; 2014 Apr 27; 15():147. PubMed ID: 24767719
[Abstract] [Full Text] [Related]
6. [Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study].
Yoshikawa N, Ito H, Takekoshi Y, Honda M, Awazu M, Iijima K, Nakamura H, Seino Y, Takeda N, Hattori S, Matsuda I.
Nihon Jinzo Gakkai Shi; 1998 Nov 27; 40(8):587-90. PubMed ID: 9893457
[Abstract] [Full Text] [Related]
7. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012 Nov 27; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
8. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul 27; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
9. Oral prednisolone for preschool children with acute virus-induced wheezing.
Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, Grigg J.
N Engl J Med; 2009 Jan 22; 360(4):329-38. PubMed ID: 19164186
[Abstract] [Full Text] [Related]
10. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May 22; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
11. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
Christian MT, Webb NJA, Mehta S, Woolley RL, Afentou N, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Prajapati H, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
JAMA Pediatr; 2022 Mar 01; 176(3):236-243. PubMed ID: 34928294
[Abstract] [Full Text] [Related]
12. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial.
Csonka P, Kaila M, Laippala P, Iso-Mustajärvi M, Vesikari T, Ashorn P.
J Pediatr; 2003 Dec 01; 143(6):725-30. PubMed ID: 14657816
[Abstract] [Full Text] [Related]
13. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan 01; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
14. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A, Hari P, Srivastava RN.
Pediatr Nephrol; 1999 Nov 01; 13(9):824-7. PubMed ID: 10603129
[Abstract] [Full Text] [Related]
15. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
[Abstract] [Full Text] [Related]
16. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 04; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
17. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term.
van Runnard Heimel PJ, Huisjes AJ, Franx A, Koopman C, Bots ML, Bruinse HW.
Eur J Obstet Gynecol Reprod Biol; 2006 May 04; 128(1-2):187-93. PubMed ID: 16412552
[Abstract] [Full Text] [Related]
18. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
19. [Prednisolone treatment of respiratory syncytial virus infection. A randomized, controlled trial of 147 children].
Bülow SL, Nir M, Levin EF, Friis B, Thomsen LL, Nielsen JE, Holm JC, Pedersen TM, Bonde-Hansen MB, Nielsen HE.
Ugeskr Laeger; 2000 Nov 20; 162(47):6404-8. PubMed ID: 11116451
[Abstract] [Full Text] [Related]
20. Risk factors for steroid dependency in children with idiopathic nephrotic syndrome.
Yap HK, Han EJ, Heng CK, Gong WK.
Pediatr Nephrol; 2001 Dec 20; 16(12):1049-52. PubMed ID: 11793098
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
